Structured Summary
Abstract
A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
14 entry terms
- Recombinant 1-165 Erythropoietin, Glycoform Alpha
- Alfa, Epoetin
- Recombinant 1 165 Erythropoietin, Glycoform Alpha
- Binocrit
- Epoetin Alfa Hexal
- Epogen
- Eprex
- HX575
- HX575 Compound
- Heberitro
- Procrit
- Alfa Hexal, Epoetin
- Compound, HX575
- Hexal, Epoetin Alfa
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, biosynthesis, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2016 (2011)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Epoetin Alfa. Medical Subject Headings (MeSH). 2026. Unique ID D000068817. http://id.nlm.nih.gov/mesh/2026/D000068817
- Epoetin Alfa. In: Wikipedia. https://en.wikipedia.org/wiki/Epoetin_alfa
- Epoetin Alfa. In: Wikidata. https://www.wikidata.org/wiki/Q5383794